Omar Nadeem, Michelle P. Aranha, Robert A. Redd, Michael Koontz, Jeffrey V. Matous, Andrew J. Yee, Jeffrey A. Zonder, Andrew Kin, Sophie Magidson, Elizabeth D. Lightbody, Ting Wu, Floris Chabrun, Jean-Baptiste Alberge, Ankit K. Dutta, Jacqueline Perry, Ashlee Sturtevant, Mahshid Rahmat, Junko Tsuji, Christine Davie, Caroline Ricciardi, Frances Arters, Marjorie Marto, Amy Bergeron, Jacalyn Rosenblatt, Elizabeth K. O’Donnell, Tarek H. Mouhieddine, Lorena Pantano, Jacob P. Laubach, Paul G. Richardson, Gad Getz, Lorenzo Trippa, Romanos Sklavenitis-Pistofidis, Irene M. Ghobrial. "Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM study." Nature Communications, 2026. doi:10.1038/s41467-026-71483-z